Merck & Co. Closes Sirna Acquisition
Friday December 29, 1:28 pm ET
Merck Closes $1.1 Billion Cash Acquisition of Sirna Therapeutics After Shareholder Vote
WHITEHOUSE STATION, N.J. (AP) -- Drug maker Merck & Co. said Friday it closed its $1.1 billion cash acquisition of the tiny biotech drug developer Sirna Therapeutics Inc. after shareholders approved the deal.
Late Thursday, Sirna shareholders voted to approve Merck's $13 per share offer, more than double the company's share price just before the offer was made in late October.
Merck offered to buy the San Francisco-based company for its RNA interference technology, a Nobel Prize-winning technique where genes responsible for diseases are "silenced" by messenger-carrying RNA.
http://biz.yahoo.com/ap/061229/merck_sirna.html?.v=1
This topic is deleted.